Canada markets close in 4 hours 13 minutes

Kane Biotech Inc. (KNE.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.1050+0.0050 (+5.00%)
As of 09:30AM EST. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) 12.48M
Enterprise Value 17.97M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)4.90
Price/Book (mrq)107.98
Enterprise Value/Revenue 7.52
Enterprise Value/EBITDA -5.42

Trading Information

Stock Price History

Beta (5Y Monthly) 0.14
52-Week Change 3-23.08%
S&P500 52-Week Change 3-12.46%
52 Week High 30.1400
52 Week Low 30.0800
50-Day Moving Average 30.0944
200-Day Moving Average 30.0956

Share Statistics

Avg Vol (3 month) 330.89k
Avg Vol (10 day) 328.35k
Shares Outstanding 5124.83M
Implied Shares Outstanding 6N/A
Float 890.48M
% Held by Insiders 126.83%
% Held by Institutions 10.00%
Shares Short (Jan 12, 2023) 44.94k
Short Ratio (Jan 12, 2023) 40.15
Short % of Float (Jan 12, 2023) 4N/A
Short % of Shares Outstanding (Jan 12, 2023) 40.00%
Shares Short (prior month Oct 30, 2022) 44.33k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Mar 12, 2017
Ex-Dividend Date 4N/A
Last Split Factor 21:5
Last Split Date 3Mar 12, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Sept 29, 2022


Profit Margin -179.57%
Operating Margin (ttm)-172.25%

Management Effectiveness

Return on Assets (ttm)-39.15%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)2.39M
Revenue Per Share (ttm)0.02
Quarterly Revenue Growth (yoy)5.60%
Gross Profit (ttm)568.44k
Net Income Avi to Common (ttm)-4.29M
Diluted EPS (ttm)-0.0420
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.26M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)6.75M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.51
Book Value Per Share (mrq)-0.05

Cash Flow Statement

Operating Cash Flow (ttm)-2.64M
Levered Free Cash Flow (ttm)-2.23M